Using your logic, the FDA is a panel made up primarily of geeks from the BEST of the scientific domain, and THEY had the power to pummel the stock. Why could not geeks on the other end BUOY the stock back UP ?
Both the FDA and Ariad are composed of medical geeks, some of the best money can buy. They simply have different agendas when looking at the SAME DATA.
I think Ariad will try to consolidate a consensus among the cancer practitioners that Iclusig IS indeed a needed therapy, and that Ariad ALSO has learned recently, the hard way, that the FDA holds sway when it comes to side effects and commensurate death rates from clots.
I am betting that the Ariad focus will be upon possible therapies to be used ALONG WITH Iclusig to limit clots (whether it be conventional therapies such as aspirin, warfarin, etc. remains to be seen). They might also present experimental designs that would allow empirical data to be colleccted to expound on the efficacy of Iclusig PLUS blood thinners. Any evidence or reinforcement of Iclusig success amond the terminally ill (who have NOT responded to other drugs) will be a HUGE plus for this company. They have everything to gain, and little to lose.
All IMHO, of course.
I think ACI re-jiggering its debt covenants had more to do with ACI's uptrend than any cold temperatures.
ACI should be selling in the 6-7 dollar range by now. That should happen soon in early 2014.
Points well taken. I think all forms of energy generation are important, and get really tired of the lame "coal is the only answer" on this board. I am long 10K shares of ACI, but do NOT view coal as "the only fuel" out there. NG, nuclear, oil, wind and solar are all viable and important. I think XOM is a tremendous way to invest long term in NG and oil. BTU, ACI and KOL are great ways to play coal, IMHO.
I am not as concerned about blood clots (this issue has be remedied in MANY other drug therapies over the years) as I am about the actual efficacy of the Iclusig molecule in survivor rate over time. There is still a lot of documentation to be done on this in the future.
My bet is that Ariad will pull off a POSITIVE salvage of this molecule (with appropriate relabeling and blood thinning protocols).
Teehee. And, that SAME Harvard campus draws its electricity from primarily two sources of fossil fuels: oil and COAL, with NG being a very distant third.
Of course, no eagles or other birds have ever succumbed to oil, nukes, or natural gas exploration.
Give me a break.
Relax. The whole "bird kill" issue with windmills is simply ludicrous. A few birds get killed and people freak out. More eagles get killed by aircraft that by windmills. In any event, eagles are alive and well, and their population is not only stable, but growing. Since they eat primarily dead fish, there is not shortage of food for these scavengers. GLTY
We're already in deep trouble. If you haven't noticed, the stock has dropped from 20+ to 2's then now up to 4's. I wouldn't be too worried about Europe right now. I'd be most concerned about re-labeling of Icusig for use in US market. Just be patient, relax, hold onto your shares. Good things will come your way. But it will take more than a few trading days (the seeming "norm" on this board).
What does having cancer to do with investing in ARIA ? Nothing. Any more than being broke has to do with investing in a bank.
Long 8K shares of ARIA. And, not emotional about it one way or another.
12 ? I doubt it. 5 ? Very probably. 6 ? I hope, and would sell there.
Go ahead and buy an Android tablet. Nobody here cares. Why would, or should, they ?
GLTY with your inferior bug-ridden Android.
AAPL is after RICH Chinese who appreciate quality, and like to possess snob appeal. So, even if that is only 3% of the population of buyers, AAPL will make several BILLION dollars by being in China.
Have a nice day. See you @ 800 early next year.
You only TAKE a loss if you DO move on. So, why move on ? That would be dumb, unless you're holding shares that you bought in the 20's.
This are, IMHO, just touches the previous gap-down floor. If it holds for the next several trading days, we may have a chance of going back to maybe mid-4. If not, we'll probably quickly fall into the previous gap into the mid-3's. GLTA. Now holding 8000 shares.